rs61749643

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 5P and 6B. PS3PP5BP4BS1_SupportingBS2

The NM_015465.5(GEMIN5):​c.3046C>T​(p.Arg1016Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00704 in 1,611,648 control chromosomes in the GnomAD database, including 58 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). ClinVar reports functional evidence for this variant: "SCV005379955: Published functional studies demonstrated reduced dimerization and ribosome association compared to wildtype (PMID:35393353);".

Frequency

Genomes: 𝑓 0.0045 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0073 ( 56 hom. )

Consequence

GEMIN5
NM_015465.5 missense

Scores

2
8
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2U:2

Conservation

PhyloP100: 6.14

Publications

13 publications found
Variant links:
Genes affected
GEMIN5 (HGNC:20043): (gem nuclear organelle associated protein 5) This gene encodes a WD repeat protein that is a component of the survival of motor neurons (SMN) complex. The SMN complex plays a critical role in mRNA splicing through the assembly of spliceosomal small nuclear ribonucleoproteins (snRNPs), and may also mediate the assembly and transport of other classes of ribonucleoproteins. The encoded protein is the snRNA-binding component of the SMN complex. Dysregulation of this gene may play a role in alternative mRNA splicing and tumor cell motility. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011]
GEMIN5 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with cerebellar atrophy and motor dysfunction
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_015465.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV005379955: Published functional studies demonstrated reduced dimerization and ribosome association compared to wildtype (PMID: 35393353);
PP5
Variant 5-154899279-G-A is Pathogenic according to our data. Variant chr5-154899279-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 562188.
BP4
Computational evidence support a benign effect (MetaRNN=0.01176995). . Strength limited to SUPPORTING due to the PP5.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00454 (692/152298) while in subpopulation NFE AF = 0.00722 (491/68022). AF 95% confidence interval is 0.00669. There are 2 homozygotes in GnomAd4. There are 314 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015465.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GEMIN5
NM_015465.5
MANE Select
c.3046C>Tp.Arg1016Cys
missense
Exon 22 of 28NP_056280.2Q8TEQ6
GEMIN5
NM_001252156.2
c.3043C>Tp.Arg1015Cys
missense
Exon 22 of 28NP_001239085.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GEMIN5
ENST00000285873.8
TSL:1 MANE Select
c.3046C>Tp.Arg1016Cys
missense
Exon 22 of 28ENSP00000285873.6Q8TEQ6

Frequencies

GnomAD3 genomes
AF:
0.00454
AC:
691
AN:
152180
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00208
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00556
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00186
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00722
Gnomad OTH
AF:
0.00574
GnomAD2 exomes
AF:
0.00460
AC:
1149
AN:
249516
AF XY:
0.00463
show subpopulations
Gnomad AFR exome
AF:
0.00216
Gnomad AMR exome
AF:
0.00433
Gnomad ASJ exome
AF:
0.00280
Gnomad EAS exome
AF:
0.0000548
Gnomad FIN exome
AF:
0.000324
Gnomad NFE exome
AF:
0.00737
Gnomad OTH exome
AF:
0.00542
GnomAD4 exome
AF:
0.00730
AC:
10654
AN:
1459350
Hom.:
56
Cov.:
30
AF XY:
0.00709
AC XY:
5144
AN XY:
725854
show subpopulations
African (AFR)
AF:
0.00153
AC:
51
AN:
33418
American (AMR)
AF:
0.00457
AC:
203
AN:
44442
Ashkenazi Jewish (ASJ)
AF:
0.00211
AC:
55
AN:
26082
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39604
South Asian (SAS)
AF:
0.00199
AC:
170
AN:
85548
European-Finnish (FIN)
AF:
0.000524
AC:
28
AN:
53400
Middle Eastern (MID)
AF:
0.00486
AC:
28
AN:
5764
European-Non Finnish (NFE)
AF:
0.00878
AC:
9750
AN:
1110792
Other (OTH)
AF:
0.00610
AC:
368
AN:
60300
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
506
1011
1517
2022
2528
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
402
804
1206
1608
2010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00454
AC:
692
AN:
152298
Hom.:
2
Cov.:
32
AF XY:
0.00422
AC XY:
314
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.00207
AC:
86
AN:
41556
American (AMR)
AF:
0.00555
AC:
85
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5180
South Asian (SAS)
AF:
0.00207
AC:
10
AN:
4828
European-Finnish (FIN)
AF:
0.0000942
AC:
1
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00722
AC:
491
AN:
68022
Other (OTH)
AF:
0.00568
AC:
12
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
30
60
91
121
151
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00600
Hom.:
1
Bravo
AF:
0.00505
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00635
EpiControl
AF:
0.00764

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
2
1
-
not provided (3)
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.21
CADD
Pathogenic
29
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.15
T
Eigen
Uncertain
0.51
Eigen_PC
Uncertain
0.53
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.95
D
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.012
T
MetaSVM
Benign
-0.36
T
MutationAssessor
Benign
1.1
L
PhyloP100
6.1
PrimateAI
Benign
0.38
T
PROVEAN
Uncertain
-2.7
D
REVEL
Uncertain
0.40
Sift
Uncertain
0.013
D
Sift4G
Uncertain
0.015
D
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Varity_R
0.35
gMVP
0.40
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs61749643;
hg19: chr5-154278839;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.